Respiratory Research Institute

Recent papers from Respiratory Research Institute

1. Second victim experiences among Austrian nonphysician emergency medical services personnelWiener klinische Wochenschrift · 2026
2. A multicentre, observational prospective study to characterise the use of inhaled triple therapy for COPD: TETRIS final results after a 24-month follow-up periodTherapeutic Advances in Respiratory Disease · 2026
3. Polydopamine–polyethylene glycol–liproxstatin-1 nanoparticles inhibit ferroptosis for enhanced treatment of neutrophilic asthmaFrontiers in Pharmacology · 2026
4. Transcriptome Profiling of Induced Sputum Identified Upregulated TNF-α/NF-κB Signalling and Downregulated Mitochondrial Respiratory Chain Function in Post-Infectious Bronchiolitis ObliteransBiomolecules · 2026
5. AZD8630/AMG 104, an inhaled anti–thymic stromal lymphopoietin antibody fragment, for moderate-to-severe asthma: Phase 1 randomized controlled trialJournal of Allergy and Clinical Immunology · 2026
6. Tiotropium vs salmeterol in GOLD II and maintenance-naïve COPD patients: Subgroup analyses of POET-COPD™ trialEuropean Respiratory Journal · 2011
7. Pedagogical priorities as a professional resource for advocacy coalition building? A Swiss Delphi study on future schoolingPolicy Futures in Education · 2025
8. TETRIS – Prospective study to observe clinical outcomes of triple therapy in COPD patients: Up to 12 months interim analysisRespiratory Medicine · 2025
9. Impact of a Digital Inhalation Coach on Inhalation Errors and Asthma ControlJournal of Aerosol Medicine and Pulmonary Drug Delivery · 2025
10. Home-Based FeNO Monitoring with the Vivatmo me Device Reveals Type 2 Inflammatory Patterns of Patients with Asthma at Different Treatment Steps: The FeNO@Home StudyPulmonary Therapy · 2025
11. Collaborative and Cooperative Hospital “In-House” Medical Device Development and Implementation in the AI Age: The European Responsible AI Development (EURAID) Framework Compatible With European ValuesJournal of Medical Internet Research · 2025
12. Comment on ‘comparative validation of handheld fractional exhaled nitric oxide measurements’Expert Review of Medical Devices · 2025
13. Clinically Important Improvements and Disease Stability with Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy in the ELLITHE Trial: A Post Hoc Responder AnalysisPulmonary Therapy · 2025
14. Cost-Effectiveness of Single-Inhaler Versus Multiple-Inhaler Triple Therapy in COPD: A German Healthcare PerspectiveInternational Journal of COPD · 2025
15. How to move towards more sustainable asthma care in Europe: an expert opinion paperBreathe · 2025
16. The Late Asthmatic Reaction Is in Part Independent from the Early Asthmatic ReactionsInternational Journal of Molecular Sciences · 2025
17. Educate Northwest Helvetia: a Delphi study on public schooling in Switzerlandforesight · 2024
18. Unmet needs of patients with COPD in Germany: a retrospective, cross-sectional studyERJ Open Research · 2024
19. Short‐course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergyAllergy · 2024
20. CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPDRespiratory Research · 2024